LFWD logo

ReWalk Robotics (LFWD) Stock

Profile

Sector:

Healthcare

Country:

Israel

IPO:

12 September 2014

Indexes:

Not included

Description:

LFWD, a part of ReWalk Robotics, focuses on developing advanced exoskeletons to assist individuals with mobility impairments. Their innovative technology aims to enhance independence and improve the quality of life for users, enabling them to walk again and regain confidence in daily activities.

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 15, 2024

Analyst ratings

Recent major analysts updates

13 Nov '24 HC Wainwright & Co.
Buy
16 Aug '24 HC Wainwright & Co.
Buy
16 May '24 HC Wainwright & Co.
Buy
15 Apr '24 HC Wainwright & Co.
Buy
28 Feb '24 HC Wainwright & Co.
Buy
15 Nov '23 HC Wainwright & Co.
Buy
14 Aug '23 HC Wainwright & Co.
Buy
10 Aug '23 HC Wainwright & Co.
Buy
03 July '23 HC Wainwright & Co.
Buy
12 May '23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript
Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript
Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript
LFWD
seekingalpha.com12 November 2024

Lifeward Ltd. (NASDAQ:LFWD ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Mike Lawless – Chief Financial Officer Larry Jasinski – Chief Executive Officer Conference Call Participants Swayampakula Ramakanth – H.C.

Lifeward to Report Third Quarter Financial Results on November 12, 2024
Lifeward to Report Third Quarter Financial Results on November 12, 2024
Lifeward to Report Third Quarter Financial Results on November 12, 2024
LFWD
globenewswire.com05 November 2024

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its third quarter 2024 financial results before the markets open on Tuesday, November 12, 2024.

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
LFWD
globenewswire.com24 October 2024

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, announced today that Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the ThinkEquity Conference on October 30, 2024.

Lifeward Launches Direct Sales of AlterG Product Line in Germany
Lifeward Launches Direct Sales of AlterG Product Line in Germany
Lifeward Launches Direct Sales of AlterG Product Line in Germany
LFWD
globenewswire.com24 September 2024

Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward's path to profitability Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward's path to profitability

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
LFWD
globenewswire.com12 September 2024

Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
LFWD
globenewswire.com10 September 2024

A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
LFWD
globenewswire.com05 September 2024

As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”)

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
LFWD
globenewswire.com02 July 2024

Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term

ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates
ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates
ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates
LFWD
Zacks Investment Research15 May 2024

ReWalk Robotics (LFWD) reported a quarterly loss of $0.73 per share, slightly higher than the Zacks Consensus Estimate of $0.70, and an increase from the loss of $0.49 per share from the same quarter last year.

ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know
ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know
ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know
LFWD
Zacks Investment Research14 May 2024

ReWalk (LFWD) could see an increase in its stock price due to increasing confidence in its earnings potential, as indicated by its upgrade to a Zacks Rank #1 (Strong Buy).

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of ReWalk Robotics?
  • What is the ticker symbol for ReWalk Robotics?
  • Does ReWalk Robotics pay dividends?
  • What sector is ReWalk Robotics in?
  • What industry is ReWalk Robotics in?
  • What country is ReWalk Robotics based in?
  • When did ReWalk Robotics go public?
  • Is ReWalk Robotics in the S&P 500?
  • Is ReWalk Robotics in the NASDAQ 100?
  • Is ReWalk Robotics in the Dow Jones?
  • When was ReWalk Robotics's last earnings report?
  • When does ReWalk Robotics report earnings?
  • Should I buy ReWalk Robotics stock now?

What is the primary business of ReWalk Robotics?

LFWD, a part of ReWalk Robotics, focuses on developing advanced exoskeletons to assist individuals with mobility impairments. Their innovative technology aims to enhance independence and improve the quality of life for users, enabling them to walk again and regain confidence in daily activities.

What is the ticker symbol for ReWalk Robotics?

The ticker symbol for ReWalk Robotics is NASDAQ:LFWD

Does ReWalk Robotics pay dividends?

No, ReWalk Robotics does not pay dividends

What sector is ReWalk Robotics in?

ReWalk Robotics is in the Healthcare sector

What industry is ReWalk Robotics in?

ReWalk Robotics is in the Medical Devices industry

What country is ReWalk Robotics based in?

ReWalk Robotics is headquartered in Israel

When did ReWalk Robotics go public?

ReWalk Robotics's initial public offering (IPO) was on 12 September 2014

Is ReWalk Robotics in the S&P 500?

No, ReWalk Robotics is not included in the S&P 500 index

Is ReWalk Robotics in the NASDAQ 100?

No, ReWalk Robotics is not included in the NASDAQ 100 index

Is ReWalk Robotics in the Dow Jones?

No, ReWalk Robotics is not included in the Dow Jones index

When was ReWalk Robotics's last earnings report?

ReWalk Robotics's most recent earnings report was on 12 November 2024

When does ReWalk Robotics report earnings?

The next expected earnings date for ReWalk Robotics is 27 February 2025

Should I buy ReWalk Robotics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions